Close Menu

NEW YORK — Oncimmune said today that it has secured an €8.5 million ($9.4 million) credit facility with Luxembourg-based financing group IPF Management.

Oncimmune said that the four-year facility will support its operations into 2021. The Nottingham, UK-based firm intends to immediately draw down €5 million with the remainder to be drawn down within six months.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.